Imaging of Precision Therapy for Lung Cancer: Current State of the Art

Radiology
Hyesun ParkMizuki Nishino

Abstract

Advances in characterization of molecular and genomic abnormalities specific to lung cancer have made precision therapy the current standard of care for lung cancer treatment. This article will provide a cutting-edge review of imaging of lung cancer in the current era of precision medicine. The focus of the article includes (a) an update on the recent advances in precision therapy for non-small cell lung cancer and their implications on imaging; (b) molecular and genomic biomarkers and pitfalls of image interpretations for lung cancer precision therapy; and (c) review of the current approaches and future directions of precision imaging for lung cancer, emphasizing emerging observations in longitudinal tumor kinetics, radiomics, and molecular and functional imaging. The article is designed to help radiologists to remain up to date in the rapidly evolving world of lung cancer therapy and serve as key members of multidisciplinary teams caring for these patients.

References

Mar 17, 2001·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·O S BreathnachB E Johnson
Aug 27, 2004·Proceedings of the National Academy of Sciences of the United States of America·William PaoHarold Varmus
Dec 23, 2008·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·E A EisenhauerJ Verweij
Aug 21, 2009·The New England Journal of Medicine·Tony S MokMasahiro Fukuoka
Aug 21, 2009·The New England Journal of Medicine·Adi F Gazdar
Nov 26, 2009·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Jedd D WolchokF Stephen Hodi
Jun 25, 2010·The New England Journal of Medicine·Makoto MaemondoUNKNOWN North-East Japan Study Group
Jul 24, 2010·AJR. American Journal of Roentgenology·Mizuki NishinoAnnick D Van den Abbeele
Feb 1, 2011·Academic Radiology·Mizuki NishinoAnnick D Van den Abbeele
Mar 25, 2011·Science Translational Medicine·Lecia V SequistJeffrey A Engelman
Jul 19, 2011·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Carlos Gomez-RocaJean-Charles Soria
Jan 27, 2012·Science Translational Medicine·Ryohei KatayamaJeffrey A Engelman
Jan 31, 2012·The Lancet Oncology·Rafael RosellUNKNOWN Spanish Lung Cancer Group in collaboration with Groupe Français de Pneumo-Cancérologie and Associazione Italiana Oncologia T
Dec 4, 2012·Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine·Gary J R CookDavid Landau
Jun 4, 2013·The New England Journal of Medicine·Alice T ShawPasi A Jänne
Jun 22, 2013·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Mizuki NishinoBruce E Johnson
Jul 3, 2013·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Lecia V SequistMartin Schuler
Jan 15, 2014·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Masayuki TakedaKazuhiko Nakagawa
Mar 29, 2014·The New England Journal of Medicine·Alice T ShawJeffrey A Engelman
Jul 2, 2014·Nature Reviews. Clinical Oncology·D Ross CamidgeLecia V Sequist
Sep 30, 2014·The New England Journal of Medicine·Alice T ShawA John Iafrate
Dec 4, 2014·The New England Journal of Medicine·Benjamin J SolomonUNKNOWN PROFILE 1014 Investigators
Jan 28, 2015·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Daniel B CostaLucio Crinò
Apr 22, 2015·The New England Journal of Medicine·Edward B GaronUNKNOWN KEYNOTE-001 Investigators
Apr 22, 2015·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Scott N GettingerJulie R Brahmer
Apr 30, 2015·The New England Journal of Medicine·Pasi A JänneMalcolm Ranson
May 16, 2015·Cancer Research·Sandra HeskampOtto C Boerman
Jun 2, 2015·The New England Journal of Medicine·Julie BrahmerDavid R Spigel
Jun 24, 2015·Cancer Immunology Research·Sree Harsha TirumaniMizuki Nishino
Jul 16, 2015·The New England Journal of Medicine·Mizuki NishinoNikhil H Ramaiya
Aug 27, 2015·Bioconjugate Chemistry·Arutselvan NatarajanSanjiv S Gambhir

❮ Previous
Next ❯

Citations

Aug 12, 2020·Journal of Fluorescence·Xiaotian XiaXiaoli Lan
Aug 17, 2021·Radiologic Clinics of North America·Katherine A ZukotynskiVictor H Gerbaudo

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Seminars in Thoracic and Cardiovascular Surgery
Arun Rajan, David S Schrump
Zhongguo fei ai za zhi = Chinese journal of lung cancer
Zhang ShiTao Jiang
Radiographics : a Review Publication of the Radiological Society of North America, Inc
Mizuki NishinoNikhil H Ramaiya
Translational Lung Cancer Research
Julie ConstanzoIssam El Naqa
© 2021 Meta ULC. All rights reserved